Drug-Eluting Balloons

This channel includes news and new technology innovations for drug coated balloons, also referred to as drug-eluting balloons. These are used to treat peripheral and coronary artery lesions and restenosis.

Medtronic, In.Pact, Admiral drug-coated balloon, DCB, drug-eluting balloon
Technology | January 05, 2015
January 5, 2015 — The U.S. Food and Drug Administration (FDA) has cleared Medtronic’s In.Pact Admiral drug-coated...
Balloon catheters, clinical trial/study, drug-eluting balloon, IN.PACT Admiral

Image courtesy of Medtronic, Inc.

News | December 29, 2014

December 29, 2014 — The results of a study published online and in Circulation indicate that a medical device from...

balloon catheters, clinical trial/study, medtronic, IN.PACT Admiral drug-coated

Photo courtesy of Medtronic

News | December 26, 2014

December 26, 2014 — The results of a landmark study published this month in Circulation indicate that a device from...

Image courtesy of Cardionovum

News | December 19, 2014

December 19, 2014 — Cardionovum GmbH announced that it has initiated a 150-patient clinical study of its novel...

News | November 14, 2014

Nov. 14, 2014 — Covidien releases 12-month results of the DEFINITIVE AR...

News | November 13, 2014

Nov. 13, 2014 — Optimizing the treatment of coronary artery disease with a new foundation for future stent...

Feature | November 10, 2014

Nov. 10, 2014 — For the treatment of ...

News | October 31, 2014

October 31, 2014 — Metro Health (Michigan) cardiovascular specialist Jihad Mustapha, M.D., is one of the first...

News | October 29, 2014

October 29, 2014 — Restenosis, the recurrence of narrowing of the arteries after stenting, is a common risk of this...

Medtronic IN.PACT Admiral Drug Coated Balloon Peripheral Artery Disease Treatmen
News | October 14, 2014

October 14, 2014 — Presented for the first time at the 2014 Transcatheter Cardiovascular Therapeutics (TCT)...

FDA Clears Lutonix 035 Drug Coated Balloon C.R. Bard Inc.
Technology | October 13, 2014

October 13, 2014 — C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approval of the Lutonix 035...

Feature | September 26, 2014
September 26, 2014 — A new clinical trial comparing the use of everolimus-eluting stents (EES) and drug-eluting...
Boston Scientific Corp. CE mark Ranger Ranger Paclitaxel-coated PTA Balloon Cath
Feature | July 28, 2014

July 28, 2014 — Boston Scientific Corp. received CE mark for the Ranger Paclitaxel-coated PTA...

agent, boston scientific, balloon catheter
News | July 25, 2014
July 25, 2014 -- Continuing to advance the development of innovative treatment options for coronary artery disease,...
FDA Recommendation Lutonix Drug Coated Balloon Catheter
Feature | June 16, 2014

June 16, 2014 — C. R. Bard Inc. announced that the U.S. Food and Drug Administration’s (FDA) Circulatory System...

Overlay Init